153 related articles for article (PubMed ID: 37875322)
21. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.
Concin N; Matias-Guiu X; Vergote I; Cibula D; Mirza MR; Marnitz S; Ledermann J; Bosse T; Chargari C; Fagotti A; Fotopoulou C; Gonzalez Martin A; Lax S; Lorusso D; Marth C; Morice P; Nout RA; O'Donnell D; Querleu D; Raspollini MR; Sehouli J; Sturdza A; Taylor A; Westermann A; Wimberger P; Colombo N; Planchamp F; Creutzberg CL
Int J Gynecol Cancer; 2021 Jan; 31(1):12-39. PubMed ID: 33397713
[TBL] [Abstract][Full Text] [Related]
22. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer.
Cibula D; Pötter R; Planchamp F; Avall-Lundqvist E; Fischerova D; Haie-Meder C; Köhler C; Landoni F; Lax S; Lindegaard JC; Mahantshetty U; Mathevet P; McCluggage WG; McCormack M; Naik R; Nout R; Pignata S; Ponce J; Querleu D; Raspagliesi F; Rodolakis A; Tamussino K; Wimberger P; Raspollini MR
Virchows Arch; 2018 Jun; 472(6):919-936. PubMed ID: 29725757
[TBL] [Abstract][Full Text] [Related]
23. Stratified follow-up for endometrial cancer: a move to more personalized cancer care.
Sarwar A; Van Griethuysen J; Waterhouse J; Dehbi HM; Eminowicz G; McCormack M
Int J Gynecol Cancer; 2021 Dec; 31(12):1564-1571. PubMed ID: 34795021
[TBL] [Abstract][Full Text] [Related]
24. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up.
Colombo N; Creutzberg C; Amant F; Bosse T; González-Martín A; Ledermann J; Marth C; Nout R; Querleu D; Mirza MR; Sessa C;
Ann Oncol; 2016 Jan; 27(1):16-41. PubMed ID: 26634381
[TBL] [Abstract][Full Text] [Related]
25. Tumor Size, an Additional Risk Factor of Local Recurrence in Low-Risk Endometrial Cancer: A Large Multicentric Retrospective Study.
Sozzi G; Uccella S; Berretta R; Petrillo M; Fanfani F; Monterossi G; Ghizzoni V; Frusca T; Ghezzi F; Chiantera V; Scambia G
Int J Gynecol Cancer; 2018 May; 28(4):684-691. PubMed ID: 29489475
[TBL] [Abstract][Full Text] [Related]
26. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer.
Cibula D; Pötter R; Planchamp F; Avall-Lundqvist E; Fischerova D; Haie Meder C; Köhler C; Landoni F; Lax S; Lindegaard JC; Mahantshetty U; Mathevet P; McCluggage WG; McCormack M; Naik R; Nout R; Pignata S; Ponce J; Querleu D; Raspagliesi F; Rodolakis A; Tamussino K; Wimberger P; Raspollini MR
Radiother Oncol; 2018 Jun; 127(3):404-416. PubMed ID: 29728273
[TBL] [Abstract][Full Text] [Related]
27. Pre-treatment risk assessment of women with endometrial cancer: differences in outcomes of molecular and clinical classifications in the Slovenian patient cohort.
Knez J; Sobocan M; Belak U; Kavalar R; Zupin M; Büdefeld T; Potocnik U; Takac I
Radiol Oncol; 2021 Sep; 56(1):76-82. PubMed ID: 34529911
[TBL] [Abstract][Full Text] [Related]
28. Impact of uterine manipulator on oncological outcome in endometrial cancer surgery.
Padilla-Iserte P; Lago V; Tauste C; Díaz-Feijoo B; Gil-Moreno A; Oliver R; Coronado P; Martín-Salamanca MB; Pantoja-Garrido M; Marcos-Sanmartin J; Gilabert-Estellés J; Lorenzo C; Cazorla E; Roldán-Rivas F; Rodríguez-Hernández JR; Sánchez L; Muruzábal JC; Hervas D; Domingo S;
Am J Obstet Gynecol; 2021 Jan; 224(1):65.e1-65.e11. PubMed ID: 32693096
[TBL] [Abstract][Full Text] [Related]
29. Predictive value of the new ESGO-ESTRO-ESP endometrial cancer risk classification on survival and recurrence in the Danish population.
Ortoft G; Høgdall C; Hansen ES; Dueholm M
Int J Gynecol Cancer; 2021 Aug; 31(8):1116-1124. PubMed ID: 34112735
[TBL] [Abstract][Full Text] [Related]
30. FIGO staging of endometrial cancer: 2023.
Berek JS; Matias-Guiu X; Creutzberg C; Fotopoulou C; Gaffney D; Kehoe S; Lindemann K; Mutch D; Concin N;
Int J Gynaecol Obstet; 2023 Aug; 162(2):383-394. PubMed ID: 37337978
[TBL] [Abstract][Full Text] [Related]
31. Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: Results from the FRANCOGYN study Group.
Bendifallah S; Ouldamer L; Lavoue V; Canlorbe G; Raimond E; Coutant C; Graesslin O; Touboul C; Collinet P; Daraï E; Ballester M;
Gynecol Oncol; 2017 Jan; 144(1):107-112. PubMed ID: 27789083
[TBL] [Abstract][Full Text] [Related]
32. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.
Concin N; Matias-Guiu X; Vergote I; Cibula D; Mirza MR; Marnitz S; Ledermann J; Bosse T; Chargari C; Fagotti A; Fotopoulou C; Martin AG; Lax S; Lorusso D; Marth C; Morice P; Nout RA; O'Donnell D; Querleu D; Raspollini MR; Sehouli J; Sturdza A; Taylor A; Westermann A; Wimberger P; Colombo N; Planchamp F; Creutzberg CL
Radiother Oncol; 2021 Jan; 154():327-353. PubMed ID: 33712263
[TBL] [Abstract][Full Text] [Related]
33. Tumor size: a better independent predictor of distant failure and death than depth of myometrial invasion in International Federation of Gynecology and Obstetrics stage I endometrioid endometrial cancer.
Chattopadhyay S; Cross P; Nayar A; Galaal K; Naik R
Int J Gynecol Cancer; 2013 May; 23(4):690-7. PubMed ID: 23518862
[TBL] [Abstract][Full Text] [Related]
34. Selection of endometrial carcinomas for p53 immunohistochemistry based on nuclear features.
Kang EY; Wiebe NJ; Aubrey C; Lee CH; Anglesio MS; Tilley D; Ghatage P; Nelson GS; Lee S; Köbel M
J Pathol Clin Res; 2022 Jan; 8(1):19-32. PubMed ID: 34596362
[TBL] [Abstract][Full Text] [Related]
35. Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes.
Smart A; Buscariollo D; Alban G; Buzurovic I; Cheng T; Pretz J; Krechmer B; King M; Lee L
Int J Gynecol Cancer; 2020 Dec; 30(12):1908-1914. PubMed ID: 32655012
[TBL] [Abstract][Full Text] [Related]
36. Clinical relevance of high-intermediate risk endometrial cancer according to European risk classification.
Rychlik A; Zapardiel I; Baquedano L; Martínez Maestre MÁ; Querleu D; Coronado Martín PJ
Int J Gynecol Cancer; 2020 Oct; 30(10):1528-1534. PubMed ID: 32817200
[TBL] [Abstract][Full Text] [Related]
37. Hormone replacement therapy for women previously treated for endometrial cancer.
Edey KA; Rundle S; Hickey M
Cochrane Database Syst Rev; 2018 May; 5(5):CD008830. PubMed ID: 29763969
[TBL] [Abstract][Full Text] [Related]
38. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer.
Cibula D; Pötter R; Planchamp F; Avall-Lundqvist E; Fischerova D; Haie Meder C; Köhler C; Landoni F; Lax S; Lindegaard JC; Mahantshetty U; Mathevet P; McCluggage WG; McCormack M; Naik R; Nout R; Pignata S; Ponce J; Querleu D; Raspagliesi F; Rodolakis A; Tamussino K; Wimberger P; Raspollini MR
Int J Gynecol Cancer; 2018 May; 28(4):641-655. PubMed ID: 29688967
[TBL] [Abstract][Full Text] [Related]
39. The association between the tumor immune microenvironments and clinical outcome in low-grade, early-stage endometrial cancer patients.
López-Janeiro Á; Villalba-Esparza M; Brizzi ME; Jiménez-Sánchez D; Ruz-Caracuel I; Kadioglu E; Masetto I; Goubert V; Garcia-Ros D; Melero I; Peláez-García A; Hardisson D; de Andrea CE
J Pathol; 2022 Dec; 258(4):426-436. PubMed ID: 36169332
[TBL] [Abstract][Full Text] [Related]
40. Back to the future: The impact of oestrogen receptor profile in the era of molecular endometrial cancer classification.
Perrone E; Capasso I; De Felice F; Giannarelli D; Dinoi G; Petrecca A; Palmieri L; Foresta A; Nero C; Arciuolo D; Lorusso D; Zannoni GF; Scambia G; Fanfani F
Eur J Cancer; 2023 Jun; 186():98-112. PubMed ID: 37062213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
